The purpose of this workshop is to facilitate discussion between FDA and other interested parties on the use of computational modeling in the design, development and evaluation of cardiovascular medical devices.
- Integration of computer and nonclinical models
- Multi-scale, multi-physics, and multi-phase modeling
- Modeling of cardiovascular diseases and therapies
- Patient-specific modeling, including virtual surgical planning and predictive biomedicine
- Open source projects, including public policy initiatives, database development and data presentation, and standards and protocols
- Regulatory issues with implementation of computer modeling
- Industry studies
Who Should Enroll
- Medical device engineers
- FDA regulators
This public workshop is intended to provide information about and gain perspective from health care providers, academia, and industry on various aspects of the use of computational modeling in the design and evaluation of cardiovascular devices. The input from this public workshop will help in promoting the use of computational modeling, encouraging collaboration amongst FDA and academia, and addressing the barriers to the implementation of computational modeling.
NOTE: During check out please indicate whether you will attend the following optional session
FDA Microstructure Modeling Session - June 9, 2010 1:30-5:00PM
Dinesh Patwardhan, Ph.D. and David Saylor, Ph.D.
The goal of this session is introduce participants to microstructure-based models and their potential application in cardiovascular devices. This session was motivated by expressed interest in diffuse-interface models developed at the FDA for microstructure formation during the fabrication of controlled drug release coatings and the impact of that microstructure on the subsequent release response with specific emphasis on drug-eluting stents.
Registration fee: $350.00
Event dates: June 10 - 11, 2010
Time: 8:00 am to 5:00 pm
Hilton Washington DC/Rockville
Executive Meeting Center
1750 Rockville Pike, Rockville, MD 20852
For More Information:
Donna R. Lochner
Division of Cardiovascular Devices
U.S. Food and Drug Administration
10903 New Hampshire Ave
Silver Spring, MD 20993-0002
For hotel information:Hotel Website